Assessment and Monitoring Asthma and Clinical Action Plan

Slides:

Advertisements

Similar presentations

Environmental Tobacco Smoke

Advertisements

Predicting risks of asthma recurrence Stephen Watt Consultant in Respiratory and Hyperbaric Medicine Aberdeen Royal Infirmary.

Managing Asthma: Asthma Management Goals Achieve and maintain control of symptoms Maintain normal activity levels, including exercise Maintain pulmonary.

Complex Medication Review Robert Hallworth Chair – Greater Manchester Non-Medical Prescribing Network Oldham Primary Care Trust.

Make your Home and Car Smoke Free for the month of March and you could win $ Protect your family Breathe easier! Register at manitobaquits.ca.

LUNG FUNCTION IN HEALTH AND DISEASE: SPIROMETRY Sultan Ayoub Meo MBBS, PGC Med Ed, PG Dip Med Ed, M.Phil, Ph.D Professor, Department of Physiology, College.

©LTPHN 2008 Respiratory Diseases Name Speaker. ©LTPHN 2008 Respiratory Disease – Global Burden Very common worldwide Substantial preventable morbidity.

Asthma What is Asthma ? V1.0 1997 Merck & ..

BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM

Managing asthma & Inhaler devices for respiratory disease.

1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.

British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.

© The Critical Thinking Consortium Children’s Rights – Caring adults # 1.

Meeting the health needs of older drug users Dr Muriel Simmonte NHS Lothian Primary Care Facilitator Team/East Lothian Locality Drug Clinic.

Lung Cancer By Jarryd Maddaford. How you get lung cancer Lung cancer is mostly given to people through smoking. 1 time out of 10 lung cancer is given.

Tobacco Use and Society. Effect on Nonsmokers Secondhand Smoke- Air contaminated by tobacco smoke. – 2 forms Mainstream smoke- smoke inhaled then exhaled.

Lung Cancer By: Jake Tyvol. What is lung cancer? Cancer itself is defined as a group of abnormal cells that don’t develop into regular tissues and divide.

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group,

How can COPD Community Services reduce hospital admissions? Glenda Esmond Respiratory Nurse Consultant West Herts Community COPD Service.

Scottish Patient Safety Programme – Pharmacist Engagement Gordon Thomson Arlene Coulson Shadi Botros.

Acute and chronic management of childhood asthma

The Health Roundtable 1-1d_HRT1212-Session_AUSTEN_GOSFORD_NSW Care Coordination decreases hospital reliance-Case Study Presenter: Alison Austen Central.

Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.

Lung Cancer Case Presentation Presenter Date:. Educational Objectives.

Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.

Looking at Frailty Through a New Lens John Strandmark, M.D. ©AAHCM.

Asthma A Presentation on Asthma Management and Prevention.

COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.

Coastal Hillside Family Medicine.  “All team based care models require some level of change in the roles and responsibilities of individual professionals,

Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.

Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:

ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.

Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.

Definition of asthma Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory.

© Global Initiative for Asthma GINA Global Strategy for Asthma Management and Prevention 2015 This slide set is restricted for academic and educational.

LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,

AUGUST Is a blend of dry botanical extracts, mixed in honey and date syrup. Each botanical extract has been authorized and defined by the Israeli.

Attaran D, Mashhad university of medical sciences.

Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.

PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.

Chronic Obstructive Pulmonary Disease in the Wessex CLAHRC -Respiratory Theme Dr Lucy Rigge, Clinical Research Fellow Collaboration for Leadership in Applied.

GLOBAL INITIATIVE FOR ASTHMA (GINA) TEACHING SLIDE SET

BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM

Global Initiative for Asthma (GINA) What’s new in GINA 2015?

The Role of the Primary Care Physician in Helping Adolescent and Adult Patients Improve Asthma Control Barbara P. Yawn, MD, MSc Mayo Clinic Proceedings

Uninsured Adults and Those with Coverage Gaps Reported Cost-Related Access Problems at Higher Rates Than Did Those Continuously Insured Percent of adults.

NAEPP Coordinating Committee

The Modern Management of Asthma: Getting it right Part 2

Fewer Women Say They Are Not Getting Needed Care Because of Costs

Women in the U.S. Report Highest Rates of Not Getting Needed Care Because of Cost Percent of women ages 19–64 who experienced any access problem because.

Adults in California and New York Reported Lower Rates of Cost-Related Access Problems Than Those in Florida and Texas Percent of adults ages 19–64 U.S.

Management of Systematic Lupus Erythematosus

Is school based directly observed therapy (DOT) in asthma always effective? (The Good, the Bad and the Ugly of DOT). Author: S Frost, J Bennett, T Evans,

Percent of adults ages 19– In the past 12 months:

Harms of Secondhand Smoking

Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.

Global Initiative for Asthma (GINA) What’s new in GINA 2015?

Women Are More Likely to Have Access Problems and Medical Bill Problems in Past Year, 2007 Percent of adults ages 19–64 reporting the following problems.

More Than One-Third of Women in the U. S. Skip Care Because of Cost vs

Service Delivery Group – January 2019

The efficacy and safety of omalizumab in pediatric allergic asthma

Percent of adults ages 19–64 who had any of four access problems

The Heart Truth Delaware Background

Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches? Stephen T. Holgate, MD, FMedSci Journal of.

Asthma Education for Families and HCPs

The Number of Adults Reporting Not Getting Needed Care Because of Cost Declined in 2014 for the First Time Since 2003 Percent of adults ages 19–

Exploring the Role of Biologics in Reducing Oral Corticosteroid Use in Severe Asthma.

Foundations of Asthma.

Tapering and Discontinuing Chronic Opioid Therapy

Effects of reslizumab on lung function (forced expiratory volume in 1 s; FEV1) in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of.

Presentation transcript:

Assessment and Monitoring Asthma and Clinical Action Plan Norsiah Ali Family Medicine Specialist Tampin Health Clinic

Assessment, monitoring & Clinical Action Plan GINA :adult & paeds Asthma Control Test (ACT) : adult & paeds PEFR normogram: Adult & Paeds Clinical action plan : adult & paeds

Global Initiative for Asthma Management (GINA) The assessment of asthma control should include control of clinical manifestations and control of expected future risk such as exacerbation, accelerated decline in lung function and side effects of treatment

GINA A. Assessment of current clinical control (preferably over the past 4 weeks) B. Assessment of future risk ( Risk of exacerbations, instability, rapid decline in lung function and side effects ): Features of increase risk of adverse event in the future : poor clinical control, frequent exacerbations in past years, ever admissions to critical care for asthma, low FEV1, exposure to cigarette smoke, high dose medications